Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06994962 · ClinicalTrials.gov registry record · NA

Multi-Component Breath Alcohol Intervention Phase 3

A NA study of Alcohol Drinking and Alcohol Use, sponsored by Northeastern University.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT06994962: Recruiting NA study of Alcohol Drinking and Alcohol Use, sponsored by Northeastern University.

NCT06994962 is a NA study of Alcohol Drinking and Alcohol Use that is actively recruiting participants, run by Northeastern University. The registered enrollment target is 90 participants, below the 629-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06994962, a NA study of Alcohol Drinking and Alcohol Use, is actively recruiting participants, sponsored by Northeastern University.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

This is the third stage of a three-stage, NIH-funded study to develop and test a multi-modal intervention concerning blood/breath alcohol concentration for young adults who drink heavily. The multimodal intervention will be made up of brief telehealth counseling and psychoeducation and use of three existing mobile technologies. The brief counseling/psychoeducation and mobile technologies provide personalized feedback regarding blood or breath alcohol content. The long-term goal of use of these mobile technologies will be to facilitate moderate drinking. However, the main goals of the proposed research are to learn more about feasibility of our procedures, perceived value of the technologies and ease of use from the research participants' points of view. In this third stage of the study, the investigators will conduct a randomized controlled trial building on the formative research conducted in Stages 1 and 2.

Primary Outcome

Percentage of reported drinking days on which one reports that moderate drinking technology use has occurred

Interventions

  • DEVICE Alcohol-related mobile health technologies
  • BEHAVIORAL Motivational interview and psychoeducation on blood/breath alcohol concentration
  • BEHAVIORAL Lower tech facilitation
  • BEHAVIORAL Higher tech facilitation
  • BEHAVIORAL Alcohol Education

Study Locations (1)

Massachusetts

  • Northeastern University - Boston

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2025-05-01
Est. Completion 2026-12-31
Phase NA
Northeastern University

39 total trials

What NCT06994962 shows while recruiting

NCT06994962 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 629-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (86% lower).

The record links to 3 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 5 interventions - of which Alcohol-related mobile health technologies is the first listed.

NCT06994962 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06994962 about?

NCT06994962 is a clinical study titled "Multi-Component Breath Alcohol Intervention Phase 3". This is the third stage of a three-stage, NIH-funded study to develop and test a multi-modal intervention concerning blood/breath alcohol concentration for young adults who drink heavily. The multimodal intervention will be made up of brief telehealth counseling and psychoeducation and use of three ...

What is the current status of trial NCT06994962?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-05-01. Estimated completion is 2026-12-31.

What conditions does trial NCT06994962 study?

This clinical trial studies the following conditions: Alcohol Drinking, Alcohol Use, Drinking Behavior.

What interventions are being tested in trial NCT06994962?

The interventions under investigation include: Alcohol-related mobile health technologies (DEVICE), Motivational interview and psychoeducation on blood/breath alcohol concentration (BEHAVIORAL), Lower tech facilitation (BEHAVIORAL), Higher tech facilitation (BEHAVIORAL), Alcohol Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT06994962?

This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06994962 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Drinking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06994962's enrollment target sits among peer trials

90 60th of 85 higher than 26 of 85 other Alcohol Drinking trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06994962, the US trial registry maintained by the National Library of Medicine. NCT06994962 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.